None listed
Conditions
Interventions
Drug : Methylphenidate 20 mg once a day for 6 months will be given orally to both ADHD patients with somatic symptoms and ADHD patients without somatic symptoms.
Sponsors
Chung-Ang Univerisity Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) ADHD with somatic symptoms ? Attention deficit and hyperactivity disorder via Structured Clinical Interview for DSM-5 (SCID-5-CV) ? 13 to 45 years old ? Did not take psychostimulant including Methylphenidate before the initial evaluation ? Having somatic symptoms based on the somatosensory amplification scores (SSAS) over 30 2) ADHD without somatic symptoms ? Attention deficit and hyperactivity disorder via Structured Clinical Interview for DSM-5 (SCID-5-CV) ? 13 to 45 years old ? Did not take psychostimulant including Methylphenidate before the initial evaluation ? Not having any somatic symptoms last 20 days
Exclusion criteria
Exclusion criteria: ? history of other psychiatric disorders diagnosed on the basis of SCID-5-CV or severe medical conditions ? BDI scores over 16 ? History of drug abuse ? History of seizures, head trauma or organic brain lesions ? Claustrophobia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In fMRI, the functional connectivity between the anterior default mode network, posterior default mode network and attention network | — |
Secondary
| Measure | Time frame |
|---|---|
| Korean version of Dupaul’s ADHD Rating Scale (K-ARS);Somato-Sensory Amplification Scale (SSAS);Beck depressive inventory (BDI);Beck Anxiety Inventory (BAI) | — |
Countries
Korea, Republic of
Contacts
Public ContactHyeri Kim
Chung-Ang Univerisity Hospital
Outcome results
None listed